Molecular Basis of Pediatric Liver Cancer

Part of paid clinical trials in Pittsburgh, Pennsylvania.

Sponsor
University of Pittsburgh
Study ID
NCT03959800
Status
Recruiting
Apply to this trial

Conditions

  • Childhood Liver Cancer
  • Embryonal Sarcoma of Liver (Disorder)
  • Hepatoblastoma
  • Hepatocellular Carcinoma
  • Liver Malignant Tumors
  • Rhabdoid Tumor of Liver

Eligibility Criteria

Sex
ALL
Age
0 Years - 99 Years
Healthy Volunteers
Not accepted

Study Details

The purpose of this retrospective and prospective project is to understand the molecular and genetic basis of liver cancer of childhood. Understanding the molecular and genetic bases of liver cancers can offer a better classification based on tumor biology, mechanisms and predisposition.

Key Dates

Start date
Jun 22, 2015
Status verified
Sep 2025
Primary completion
Jun 30, 2028
Completion
Jun 30, 2029

Study Design

Enrollment
1,600 participants (estimated)

Primary Outcome Measure

Gene sequencing [ Time Frame: Recurrence free survival at 2 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
UPMC Children's Hospital of PittsburghPittsburghPennsylvania15224
Morgan L Paul, BSN
[email protected]
412-692-8472
Daniel Pieratt, MPA
[email protected]
4126926692
Rakesh Sindhi, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Pittsburgh, PA

By condition
Liver cancer
By specialty
OncologyGI oncologyHepatology
By research site
UPMC Children's Hospital of Pittsburgh· Pittsburgh, PA

Related Studies